To vaccinate just 70 percent of the world’s population against COVID-19 will require around 11 billion doses, based on two doses per person. The scale of the challenge facing the pharma industry is enormous. How do we manufacture billions of doses? This week’s articles examine just some of the challenges affecting a global immunization program.
|